Education
About Us
Working with TipRanks
Follow Us
CTT Pharmaceutical Holdings Inc (CTTH)
OTHER OTC:CTTH
Total Valuation
CTT Pharmaceutical Holdings has a market cap or net worth of $5.15M. The enterprise value is $1.91M.
Market Cap$5.15M
Enterprise Value$1.91M
Share Statistics
CTT Pharmaceutical Holdings has 58,712,230 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding58,712,230
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
CTT Pharmaceutical Holdings’s return on equity (ROE) is -6.53 and return on invested capital (ROIC) is -509.00%.
Return on Equity (ROE)-6.53
Return on Assets (ROA)-2.88
Return on Invested Capital (ROIC)-509.00%
Return on Capital Employed (ROCE)-7.77
Revenue Per Employee0.00
Profits Per Employee-104.76K
Employee Count2
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of CTT Pharmaceutical Holdings is ―. CTT Pharmaceutical Holdings’s PEG ratio is -0.04.
PE Ratio―
PS Ratio0.00
PB Ratio92.48
Price to Fair Value92.48
Price to FCF-87.87
Price to Operating Cash Flow-73.52
PEG Ratio-0.04
Income Statement
In the last 12 months, CTT Pharmaceutical Holdings had revenue of 0.00 and earned -210.00K in profits. Earnings per share was 0.00.
Revenue0.00
Gross Profit-6.40K
Operating Income-250.00K
Pretax Income-210.00K
Net Income-210.00K
EBITDA-243.83K
Earnings Per Share (EPS)0.00
Cash Flow
In the last 12 months, operating cash flow was -53.20K and capital expenditures -5.00, giving a free cash flow of -53.21K billion.
Operating Cash Flow-53.20K
Free Cash Flow-53.21K
Free Cash Flow per Share>-0.01
Dividends & Yields
CTT Pharmaceutical Holdings pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.00
52-Week Price Change-13.00%
50-Day Moving Average0.07
200-Day Moving Average0.05
Relative Strength Index (RSI)61.29
Average Volume (3m)66.33K
Important Dates
CTT Pharmaceutical Holdings upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
CTT Pharmaceutical Holdings as a current ratio of <0.01, with Debt / Equity ratio of 21.19%
Current Ratio<0.01
Quick Ratio<0.01
Debt to Market Cap<0.01
Net Debt to EBITDA-0.07
Interest Coverage Ratio-122.37
Taxes
In the past 12 months, CTT Pharmaceutical Holdings has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
CTT Pharmaceutical Holdings EV to EBITDA ratio is -12.28, with an EV/FCF ratio of -88.37.
EV to Sales0.00
EV to EBITDA-12.28
EV to Free Cash Flow-88.37
EV to Operating Cash Flow-88.37
Balance Sheet
CTT Pharmaceutical Holdings has $32.44K in cash and marketable securities with $17.40K in debt, giving a net cash position of $15.04K billion.
Cash & Marketable Securities$32.44K
Total Debt$17.40K
Net Cash$15.04K
Net Cash Per Share<$0.01
Tangible Book Value Per Share>-$0.01
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for CTT Pharmaceutical Holdings is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―